Talk — Anonymous Pharma Rep Forum

69 anonymous posts from pharmaceutical sales representatives across 112 companies.

Recent Posts

• BMS CV reps — are you hearing anything about Q3 headcount decisions? — Bristol Myers Squibb · 38 upvotes · 6 comments
• Novo pod restructuring wiping out whole districts — anyone else get the call? — Novo Nordisk · 47 upvotes · 5 comments
• Amgen post-Horizon integration still a mess — Tepezza access getting worse — Amgen · 43 upvotes · 5 comments
• J&J remapping whole territories March 31 — anyone affected? — Johnson & Johnson (Janssen) · 52 upvotes · 5 comments
• B&L NSM 2026 quota setting — did anyone else leave feeling scammed? — Bausch Health · 67 upvotes · 5 comments
• Novartis routing PTO claims through MetLife now — anyone else hit delays? — Novartis · 61 upvotes · 6 comments
• Is it ever the right time to leave big pharma for a smaller biotech? — Pfizer · 88 upvotes · 6 comments
• Pfizer oncology comp — negotiation tips from someone who pushed back — Pfizer · 30 upvotes · 0 comments
• Pfizer post-COVID — what the restructure actually felt like — Pfizer · 13 upvotes · 0 comments
• Keytruda expansion — great for science, brutal for reps — Merck (MSD) · 26 upvotes · 0 comments
• AbbVie culture from someone who stayed 8 years — AbbVie · 25 upvotes · 0 comments
• AbbVie Skyrizi launch in IBD — one year in — AbbVie · 38 upvotes · 0 comments
• GSK respiratory — Nucala vs Fasenra still going strong — GlaxoSmithKline (GSK) · 40 upvotes · 0 comments
• Dupixent access in atopic derm — my honest 2026 update — Sanofi · 27 upvotes · 0 comments
• Repatha managed care — still fighting for every script — Amgen · 15 upvotes · 0 comments
• Lilly pay is top of market but pressure is insane — Eli Lilly · 11 upvotes · 0 comments
• Lilly GLP-1 territory — managing demand that exceeds supply — Eli Lilly · 41 upvotes · 0 comments
• AZ is the best managed company I have worked for — change my mind — AstraZeneca · 10 upvotes · 0 comments
• BMS layoffs round 2 — southeast getting cut — Bristol Myers Squibb · 22 upvotes · 6 comments
• Opdivo + Yervoy combo — competitive update from the field — Bristol Myers Squibb · 44 upvotes · 0 comments
• Tremfya vs Skyrizi — DM keeps telling us not to worry — Johnson & Johnson (Janssen) · 6 upvotes · 0 comments
• Vyvgart field experience — what new reps should know — argenx · 6 upvotes · 0 comments
• Alnylam comp and culture — honest 2-year review — Alnylam Pharmaceuticals · 45 upvotes · 6 comments
• Jakafi biosimilar threat — what leadership is telling us vs reality — Incyte · 17 upvotes · 0 comments
• Caplyta MDD indication changing my territory completely — Intra-Cellular Therapies · 35 upvotes · 0 comments

Post anonymously · News · Companies